CANADIAN PERSPECTIVE Series
Navigating Adverse Events in HR+/HER2- Metastatic Breast Cancer: A Canadian and International Perspective on Approved Therapies
septembre 2025
Résumé
Join us for an engaging webinar featuring presentations by renowned U.S. oncologists Dr. Hope Rugo and Dr. Komal Jhaveri. Together with respected Canadian moderator Dr. Jean-Pierre Ayoub, they will draw on both international and Canadian perspectives to deliver key clinical insights and practical strategies. Dr. Ayoub will bring a particular focus on the Canadian context throughout the discussion. The session will explore the management of adverse events associated with approved therapies in HR+/HER2- metastatic breast cancer and highlight practical approaches to optimizing patient care.
This activity has been funded by an educational grant from AstraZeneca and is intended for healthcare practitioners only.
Commentaires (0)